Skip to content
Press Release
FEATURED | May 1, 2026

Jason Chambers Teams Up with the Melanoma Researc...

Superyacht Captain, Star of Bravo’s “Below Deck Down Under” and Melanoma Advocate Urges All to Embrace Healthy Sun-Safe Behaviors and #GetNaked…It May Save Your...

5 Minute Read
December 23, 2023

Understanding the Role of Peroxisomes in Regulatin...

Medical Student Award – Stephanie Mills

1 Minute Read
December 23, 2023

Risk Factor Analysis of Young Patients with Uveal ...

Medical Student Award – Arina Nisanova

1 Minute Read
December 23, 2023

Investigating the Systemic Microbiome in Mucosal M...

Medical Student Award – Pritika Parmar

1 Minute Read
December 23, 2023

Mechanisms of Macrophage Evasion in Residual Melan...

Medical Student Award – Jude Raj

1 Minute Read
December 23, 2023

Defining the dynamics of ICOS+ CD4 T cell response...

Medical Student Award – Megen Wittling

1 Minute Read
December 23, 2023

Targeting the eIF4F, Translation Initiation Comple...

The translation initiation complex (or TIC) is one of the last unexplored targets in cancer therapy or melanoma. Protein production is tightly controlled by a complex of fo...

1 Minute Read
December 19, 2023

NKT infiltration and rejection in melanomas

Current immunotherapies have dramatically improved clinical outcomes, but more than half of metastatic melanoma patients have poor responses and primary resistance. With ti...

1 Minute Read
December 19, 2023

TGFßi NK Cell Infusions in Patients with Melanoma...

Brain metastases remain a leading cause of death in patients with metastatic melanoma. One of the most exciting advances in the treatment of CNS metastases was combined che...

2 Minute Read
December 19, 2023

Targeting an adaptor function of CDK6 to enhance m...

Immunotherapy has been remarkably successful in the treatment of melanoma, but not all patients benefit from therapy and its effects is in most cases temporary, followed by...

1 Minute Read
December 19, 2023

Immunogenic landscape and therapeutic targeting of...

Many cancer immunotherapy patients fail to respond or progress after initially experiencing tumor regression. More than 25% of melanomas carry activating mutations in the d...

1 Minute Read
December 19, 2023

Targeting melanoma with engineered CD4+ T cells

Both helper CD4 T cells and killer CD8 T cells are known to be involved in immune responses to cancer. Helper CD4 T cells assist immune responses to cancer by enhancing the...

2 Minute Read
December 19, 2023

Deciphering the role of APRIL/TNFSF13 in melanoma-...

The overall survival of a subset of patients with melanoma drastically improved with a type of treatment called immunotherapy, which activates the body’s immune system to...

1 Minute Read

Jun 13, 2026 MT

Denver Miles for Melanoma 5K

Jul 19, 2026 CT

Chicago Miles for Melanoma 5K

Jul 30, 2026 ET

Ask the Expert: The Evolving Role of ctDNA in Melanoma Treatment and Surveillance

Aug 02, 2026 ET

Cleveland Miles for Melanoma 5K

Aug 22, 2026 ET

Philadelphia Miles for Melanoma 5K

Aug 30, 2026 PT

San Francisco Miles for Melanoma 5K

Aug 30, 2026 CT

Twin Cities Miles for Melanoma 5K

Explore Events